Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
It helps you keep the routine your licensed clinician prescribed
GLP-1 Agonist Comparison 2026: Semaglutide vs Tirzepatide vs Retatrutide vs Orforglipron Compare four GLP-1 receptor agonists in 2026: semaglutide, tirzepatide, retatrutide, and orforglipron
It's against that backdrop that semaglutide - and other drugs on the horizon - promise to do something different
Annual per-patient costs of $12,000 to $16,000 for brand-name GLP-1 medications, combined with the massive number of potentially eligible patients (roughly 42% of American adults have obesity), create projected costs that threaten to destabilize employer health plans
Contaminated or improperly synthesized peptides can introduce unknown variables and potential risks into your research
This may be helpful for those at higher risk for certain cancers, at least in theory
US$ 28.68
US$ 20.43
US$ 28.37
US$ 24.88
US$ 28.04
US$ 28.45
US$ 23.37
US$ 24.54
US$ 29.21
US$ 23.79
US$ 29.95
